The year's new drugs & biologics 2016: Part II - Trends and highlights of an unforgettable year.
Drugs Today (Barc)
; 53(2): 117-158, 2017 Feb.
Article
in En
| MEDLINE
| ID: mdl-28387389
ABSTRACT
This eagle's-eye overview of the drug industry in 2016 provides insight into some of last year's top stories, including disease outbreaks that drove R&D, orphan drug development, pipeline attrition, drug pricing, and the ongoing movement in M&A. We also consider recent political events in the U.S. and U.K. and their potential impact on the industry in the years to come, and take a glimpse into the crystal ball to anticipate the new drugs that may be approved in 2017.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biological Products
/
Drugs, Investigational
/
Drug Industry
/
Drug Discovery
Type of study:
Prognostic_studies
/
Sysrev_observational_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Drugs Today (Barc)
Journal subject:
MEDICINA OCUPACIONAL
/
SAUDE AMBIENTAL
Year:
2017
Document type:
Article
Affiliation country: